resourcing

Job Basket

Please browse our site for vacancies then sign up

Sign Up Anyway
News Pharmacy News Archive Pharmacy News Optometry News
UK and Eire Glaucoma Society Annual Meeting Stem Cell Ruling Puts Halt to Sight-Saving Research A Summer of Product Recalls for Contact Lens Solutions? Cameron told to Cut GOC Bureaucracy End To Free Eye Exams GOC Hits Back at AOP Criticism Murray Wells want to ‘demystify optics' GOC told to cut costs before raising fees NHS Hotspots Impact Business and Salary. Increase in GOC Fees Looming Scotland’s Free Eye Tests under Threat. Welsh Optoms reimbursed for CET Specsavers vs Asda High Court Judgement. NHS Tests on the Rise New Tests for Drivers Eye on Testing Times AMD Under the Telescope Central Retinal Vein Occlusion gets a By-Pass Optegra Expands in Hampshire Eye Love Local! Headteachers Targeted by Campaign Manchesters Heroes Going the extra mile for VAO Ocutec secures further funding for new contact lens Huge sum is invested in Optical Express clinics Optegra buys Yorkshire Eye Hospital Asda focus on Contact Lens market Eye surgeon calls for Avastin on the NHS Vision CRC breakthrough technology controls myopia in children GOC to consult on new CET scheme from 2013 Women in optics on the increase Boots Named Top Place to Work by The Sunday Times Green Tea May Ward Off Eye Disease Glaucoma Begins in Mid-Brain, Not in Eye, Research Shows AOP Student Conference 2010 Economies and eye health to be debated in March Anglia suspends 2010 dispensing courses EPIC eye care scheme launched Results of a New Femtosecond Laser Treatment for Presbyopia Use of Glaucoma Medication Linked to Reduced Likelihood of Death
Archive Optometry News Dentistry News

AMD under the Telescope

A tiny telescope device which is implanted into the eye to restore sight has been approved for use in the USA. The first-of-its-kind Implantable Miniature Telescope (IMT) is designed to improve the vision of patients with end-stage age-related macular degeneration.

AMD under the Telescope 

Replacing the patient's natural lens, the device improves visual acuity and reduces the impact of the blind spot in the patient's central vision which is caused by advanced AMD. Once implanted the telescope works by enlarging images in front of the eye by more than twice their normal size.

 

The device is designed for use on patients 75-years-old and over who have stable vision impairment that is classed as severe to profound.

The IMT is implanted behind the iris in one eye during a brief outpatient surgical procedure. The other eye is left without an implant so that peripheral vision is retained for safe mobility and navigation

 

Invented by Dr. Isaac Lipshitz, the IMT underwent clinical investigation in Europe, the U.S., and elsewhere, which reported that 75% of patients vision improved from severe or profound impairment to moderate.  Developers of the telescope, California-based VisionCare will carry out two further studies on the device. The first monitoring existing patients and the second on 770 new patients for five-years after implanting.